Results for "Rare Disorders"
Conditions Encyclopedia Entry 1778963165
** This encyclopedia entry is about a rare and complex medical condition known as **Ehlers-Danlos Syndrome (EDS)**, a group of genetic disorders that affect the body's connective tissue. ## Overview Ehlers-Danlos Syndrome (EDS) is a rare genetic disorder that affects the body's connective tissue, which provides support and structure to various organs, joints, and other body parts. The condition is characterized by extremely flexible joints, skin hyperextensibility, and tissue fragility. People with EDS often experience chronic pain, fatigue, and a range of other symptoms that can significantly impact their quality of life. EDS is a complex condition that can be challenging to diagnose, and its symptoms can vary widely from person to person. There are 13 subtypes of EDS, each with distinct characteristics and symptoms. The most common subtypes are Classical EDS (cEDS), Hypermobile EDS (hEDS), and Vascular EDS (vEDS). While some people with EDS may experience mild symptoms, others may face life-threatening complications, such as organ rupture or sudden death. Despite its rarity, EDS affects approximately 1 in 5,000 to 1 in 20,000 people worldwide. ## History/Background The first reported case of EDS was in 1901 by the French dermatologist Edouard Ehlers, who described a patient with extremely flexible joints and skin hyperextensibility. In 1936, the American dermatologist Henri-Alexandre Danlos expanded on Ehlers' findings, describing the condition as a distinct clinical entity. Since then, research has continued to uncover the genetic and molecular mechanisms underlying EDS, leading to a greater understanding of the condition and its various subtypes. ## Key Information EDS is caused by mutations in genes that encode for proteins involved in the production and maintenance of collagen, a key component of connective tissue. The condition is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. While EDS is a genetic disorder, its symptoms can be triggered or exacerbated by various factors, such as physical trauma, stress, or certain medications. People with EDS often experience a range of symptoms, including: * Joint hypermobility and instability * Skin hyperextensibility and fragility * Tissue fragility and easy bruising * Chronic pain and fatigue * Gastrointestinal issues, such as constipation or diarrhea * Orthostatic intolerance and postural orthostatic tachycardia syndrome (POTS) ## Significance Ehlers-Danlos Syndrome is a significant condition that affects not only individuals but also their families and communities. While it is a rare condition, EDS has a profound impact on the lives of those affected, often leading to chronic pain, disability, and social isolation. However, with increased awareness and understanding of the condition, people with EDS are now able to access better diagnosis, treatment, and support. Research into EDS has also led to a greater understanding of the underlying biology of connective tissue and its role in various diseases. This knowledge has implications for the development of new treatments and therapies for a range of conditions, including osteoarthritis, fibromyalgia, and other connective tissue disorders. ## INFOBOX: - **Name:** Ehlers-Danlos Syndrome (EDS) - **Type:** Genetic disorder, connective tissue disorder - **Date:** First reported case in 1901 - **Location:** Worldwide, with varying prevalence rates - **Known For:** Rare genetic disorder affecting connective tissue, characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. ## TAGS: Genetics, Connective Tissue, Rare Disorders, Chronic Pain, Fatigue, Joint Instability, Skin Fragility, Gastrointestinal Issues, Orthostatic Intolerance.
Health & MedicineConditions Encyclopedia Entry 1780479364
** **Mitochondrial Myopathies** are a group of rare genetic disorders characterized by the degeneration of muscle tissue due to impaired mitochondrial function, leading to a range of symptoms including muscle weakness, fatigue, and pain. **CONTENT:** ### Overview Mitochondrial myopathies are a complex group of disorders that affect the mitochondria, the energy-producing structures within cells. These organelles are responsible for generating energy in the form of ATP (adenosine triphosphate) through a process called oxidative phosphorylation. When the mitochondria are impaired, cells cannot produce enough energy, leading to a range of symptoms. Mitochondrial myopathies are often inherited in an autosomal dominant or mitochondrial pattern, meaning that a single copy of the mutated gene is enough to cause the condition. There are over 150 known mitochondrial myopathies, each with its unique set of symptoms and characteristics. Mitochondrial myopathies can affect any muscle group, but they often target the skeletal muscles, leading to muscle weakness, fatigue, and pain. Other symptoms may include shortness of breath, heart problems, and vision and hearing loss. The severity of the condition can vary greatly, ranging from mild to severe, and may progress over time. In some cases, mitochondrial myopathies can be life-threatening, particularly if left untreated or if the condition is severe. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and fatigue. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of researchers led by Dr. Doug Wallace identified the first mitochondrial DNA mutation associated with a myopathy. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying mitochondrial myopathies. ### Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA or nuclear DNA that affect the function of the mitochondria. These mutations can be inherited from one's parents or occur spontaneously. Some of the most common types of mitochondrial myopathies include: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a severe form of mitochondrial myopathy characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonus Epilepsy with Ragged-Red Fibers (MERRF)**: a rare form of mitochondrial myopathy characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre Syndrome (KSS)**: a rare form of mitochondrial myopathy characterized by muscle weakness, heart problems, and vision loss. ### Significance Mitochondrial myopathies are a significant cause of morbidity and mortality worldwide. According to the National Institutes of Health (NIH), mitochondrial myopathies affect approximately 1 in 5,000 people in the United States. While there is no cure for these disorders, various treatments are available to manage symptoms and slow disease progression. These include medications to alleviate muscle weakness and pain, as well as physical therapy and rehabilitation to improve mobility and function. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic Disorders - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Complex group of disorders affecting mitochondrial function and leading to muscle weakness, fatigue, and pain. **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Pain, Mitochondrial Function, Energy Production, ATP, Oxidative Phosphorylation, Autosomal Dominant, Mitochondrial Pattern, Rare Disorders, Complex Conditions.